Genome Biology Group
We investigate cancer genomes by integrated computational and laboratory based approaches. Our aim is to identify and characterise critical genes involved in the cancer development. Such genes may serve as diagnostic or prognostic biomarkers and also as targets for future molecularly tailored therapy. Our studies are mainly focused on testicular, prostate and colorectal cancers.
| RESEARCH THEMES |
Transcript variants in cancer from exon microarrays and deep sequencing
Testicular germ cell tumour: Malignancy specific expression in a stem cells context (Skotheim is Principal Investigator in the Centre for Research-based Innovation in Cancer Stem Cells) and genetic studies of bilateral disease
Fusion genes: a universal detection tool and novel fusion transcripts
Group contact information
Oslo University Hospital HE - Norwegian Radium Hospital
Mail address: P. O. Box 4953 Nydalen, NO-0424 Oslo, Norway
Street address: Norwegian Radium Hospital, Montebello
Phone: +47 2278 1727 / +47 2293 4000
E mail: rolf.i.skotheim(a)rr-research.no
Latest publications
Genome Biology Group
Meta-analysis identifies four new loci associated with testicular germ cell tumor
Nat Genet (in press)
PubMed 23666239
Molecular Characteristics of Malignant Ovarian Germ Cell Tumors and Comparison With Testicular Counterparts: Implications for Pathogenesis
Endocr Rev (in press)
PubMed 23575763
Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23
Hum Mol Genet (in press)
PubMed 23462292
More publications





Print this page
